Prevalence and characteristics in long COVID among adults with asthma in the United States
- 16 January 2024
- journal article
- research article
- Published by Taylor & Francis in Journal of Asthma
- Vol. 61 (7) , 736-744
Abstract
The purpose of this study was to assess: (1) the prevalence of long COVID by asthma status, and (2) the characteristics associated with developing long COVID among adults with asthma in the United States. Data from the 2022 National Health Interview Survey were used. The prevalence of long COVID was reported and stratified by asthma status. The multivariable logistic regression model was conducted to identify the factors associated with developing long COVID. In 2022, the overall prevalence of long COVID among U.S. adults was 6.9%. When stratified by asthma status, the prevalence of long COVID was 13.9% among adults with asthma, and 6.2% among adults without asthma. Among adults with asthma, certain characteristics, including age over 55 years, female sex, obesity, problems paying medical bills and a history of asthma attacks, were significantly associated with developing long COVID. This study revealed that the prevalence of long COVID among adults with asthma was much higher than the general adult population in the United States. The limited validity of the collected information in this study should prompt caution when interpreting our findings. Further studies on the association between asthma and long COVID could be valuable for the clinical practice.Keywords
This publication has 41 references indexed in Scilit:
- Asthma is a risk factor for general fatigue of long COVID in Japanese nation-wide cohort studyAllergology International, 2023
- Risk Factors Associated With Post−COVID-19 ConditionJAMA Internal Medicine, 2023
- Toward a Universal Definition of Post–COVID-19 Condition—How Do We Proceed?JAMA Network Open, 2023
- Definition of Post–COVID-19 Condition Among Published Research StudiesJAMA Network Open, 2023
- Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021JAMA, 2022
- Rates and Factors Associated With Documentation of Diagnostic Codes for Long COVID in the National Veterans Affairs Health Care SystemJAMA Network Open, 2022
- The presence of symptoms within 6 months after COVID-19: a single-center longitudinal studyIrish Journal of Medical Science (1971 -), 2022
- Persistence of symptoms after improvement of acute COVID19 infection, a longitudinal studyJournal of Medical Virology, 2021
- Sex differences in COVID-19: the role of androgens in disease severity and progressionEndocrine, 2020
- A comparison study of SARS‐CoV‐2 IgG antibody between male and female COVID‐19 patients: A possible reason underlying different outcome between sexJournal of Medical Virology, 2020